Truist has made the decision to lower its target price for Insmed, a move that comes as competitive pressures in the industry continue to increase.
This adjustment indicates a response to the changing dynamics within the market that may impact Insmed's performance.
Investors and analysts will likely be monitoring how these competitive factors influence Insmed's future prospects.